相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bayesian analysis of genome-wide inflammatory bowel disease data sets reveals new risk loci
Yu Zhang et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Abnormalities of signal transduction networks in chronic schizophrenia
Jennifer L. McGuire et al.
NPJ SCHIZOPHRENIA (2017)
Gene expression elucidates functional impact of polygenic risk for schizophrenia
Menachem Fromer et al.
NATURE NEUROSCIENCE (2016)
Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation
Natalie Matosin et al.
ACTA NEUROPATHOLOGICA (2015)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
Colm O'Dushlaine et al.
NATURE NEUROSCIENCE (2015)
Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents
Jerri M. Rook et al.
NEURON (2015)
Norbin ablation results in defective adult hippocampal neurogenesis and depressive-like behavior in mice
Hong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia
Natalie Matosin et al.
SCHIZOPHRENIA RESEARCH (2015)
Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia
A. Banerjee et al.
MOLECULAR PSYCHIATRY (2015)
Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics
Kelly A. Newell et al.
BMC PSYCHIATRY (2014)
Altered serine/threonine kinase activity in schizophrenia
Jennifer L. McGuire et al.
BRAIN RESEARCH (2014)
Activation of mGluR5 Attenuates NMDA-Induced Neurotoxicity through Disruption of the NMDAR-PSD-95 Complex and Preservation of Mitochondrial Function in Differentiated PC12 Cells
Shu-Hui Dai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics
Natalie Matosin et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2014)
Modulation of neuronal microcircuit activities within the medial prefrontal cortex by mGluR5 positive allosteric modulator
Marie Pollard et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Copy number variation in schizophrenia in Sweden
J. P. Szatkiewicz et al.
MOLECULAR PSYCHIATRY (2014)
A polygenic burden of rare disruptive mutations in schizophrenia
Shaun M. Purcell et al.
NATURE (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia
Dor Mohammad Kordi-Tamandani et al.
GENE (2013)
Glutamate, Glutamate Receptors, and Downstream Signaling Pathways
Stacey S. Willard et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
The mGlu(5) positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat
Francois Gastambide et al.
NEUROPHARMACOLOGY (2013)
Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia
Natalie Matosin et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Metabotropic Glutamate Receptors and Interacting Proteins: Evolving Drug Targets
Ralf Enz
CURRENT DRUG TARGETS (2012)
Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
N. Hovelso et al.
CURRENT NEUROPHARMACOLOGY (2012)
Glutamatergic transmission in schizophrenia: from basic research to clinical practice
Joshua Kantrowitz et al.
CURRENT OPINION IN PSYCHIATRY (2012)
Preso1, mGluR5 and the machinery of pain
Jelena Radulovic et al.
NATURE NEUROSCIENCE (2012)
Preso1 dynamically regulates group I metabotropic glutamate receptors
Jia-Hua Hu et al.
NATURE NEUROSCIENCE (2012)
Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats
S. W. Fowler et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Colleen M. Niswender et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
John H. Krystal et al.
CNS DRUGS (2010)
Group 5 metabotropic glutamate receptors: Role in modulating cortical activity and relevance to cognition
Houman Homayoun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation
Laura Gray et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning
Jennifer E. Ayala et al.
NEUROPSYCHOPHARMACOLOGY (2009)
The Post-Synaptic Density of Human Postmortem Brain Tissues: An Experimental Study Paradigm for Neuropsychiatric Illnesses
Chang-Gyu Hahn et al.
PLOS ONE (2009)
Norbin Is an Endogenous Regulator of Metabotropic Glutamate Receptor 5 Signaling
Hong Wang et al.
SCIENCE (2009)
Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors
Julie Perroy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MGluR5 Mediates the Interaction between Late-LTP, Network Activity, and Learning
Arthur Bikbaev et al.
PLOS ONE (2008)
AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs
J. A. O'Connor et al.
SCHIZOPHRENIA RESEARCH (2007)
The role of protein interaction motifs in regulating the polarity and clustering of the metabotropic glutamate receptor mGluR1a
Sonal S. Das et al.
JOURNAL OF NEUROSCIENCE (2006)
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia
Chang-Gyu Hahn et al.
NATURE MEDICINE (2006)
Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis
Gurpreet K. Dhami et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia
DS Gupta et al.
SYNAPSE (2005)
The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison
TM Ballard et al.
PSYCHOPHARMACOLOGY (2005)
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
PJ Harrison et al.
MOLECULAR PSYCHIATRY (2005)
NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin
S Alagarsamy et al.
NEUROPHARMACOLOGY (2005)
Functional interaction between NMDA and mGlu5 receptors: Effects on working memory, instrumental learning, motor behaviors, and dopamine release
H Homayoun et al.
NEUROPSYCHOPHARMACOLOGY (2004)
NMDA-induced phosphorylation and regulation of mGluR5
S Alagarsamy et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Tyrosine phosphorylation of the metabotropic glutamate receptor mGluR5 in striatal neurons
LR Orlando et al.
NEUROPHARMACOLOGY (2002)
Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins
J Kitano et al.
JOURNAL OF NEUROSCIENCE (2002)
Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies
M. J. Marino et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia
RS Devon et al.
MOLECULAR PSYCHIATRY (2001)
Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges
S Attucci et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus
SM Richardson-Burns et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
